STOKEWOOD SURGERY — All Prescriptions & Medications — Page 9
Practice Code: J82018 | EASTLEIGH, SO50 8AU
Showing results 401-450 of 771
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Other compound vitamin/mineral formulation preparations | 66 | 1,134 | £164 | +105.8% ▲ |
| Aliskiren | 65 | 1,071 | £1.2K | +1,163.2% ▲ |
| Diphtheria | 65 | 65 | £473 | -2.6% ▼ |
| Biphasic isophane insulin | 64 | 520 | £2.2K | -42.6% ▼ |
| Adapalene and benzoyl peroxide | 63 | 3,435 | £1.5K | +18.0% ▲ |
| 63 | 518 | £15.1K | +76.4% ▲ | |
| Fenofibrate | 62 | 2,408 | £261 | -35.9% ▼ |
| Salmeterol | 62 | 113 | £3.3K | +157.8% ▲ |
| Medroxyprogesterone acetate | 61 | 3,373 | £606 | +59.4% ▲ |
| RtS 2-2.4 kcal/ml m/sk higher protein,higher energy(0913011) | 61 | 583.6K | £6.6K | +39.4% ▲ |
| Pimecrolimus | 61 | 2,990 | £1.8K | +260.3% ▲ |
| Acetylcysteine | 60 | 1,102 | £2.6K | -16.1% ▼ |
| Atomoxetine hydrochloride | 60 | 3,038 | £6.1K | +77.4% ▲ |
| Ertugliflozin | 60 | 840 | £844 | +232.6% ▲ |
| 60 | 543 | £554 | +92.7% ▲ | |
| 60 | 2,071 | £2.7K | +267.6% ▲ | |
| Biphasic insulin aspart | 59 | 670 | £3.9K | -41.9% ▼ |
| Ins degludec/liraglutide | 59 | 261 | £8.3K | +267.0% ▲ |
| Emollient bath and shower preparations | 59 | 21.3K | £307 | -6.1% ▼ |
| Menthol | 58 | 30.3K | £1.1K | +106.0% ▲ |
| 58 | 150 | £972 | +62.3% ▲ | |
| Co-amilofruse (Amiloride hydrochloride/frusemide) | 57 | 3,304 | £448 | +63.9% ▲ |
| Prucalopride | 56 | 1,204 | £791 | +43.8% ▲ |
| Imipramine hydrochloride | 56 | 6,076 | £222 | +119.7% ▲ |
| Cinnarizine | 56 | 4,749 | £220 | +19.7% ▲ |
| 56 | 565 | £221 | +93.4% ▲ | |
| Citalopram hydrochloride | 54 | 915 | £632 | +236.4% ▲ |
| Alprostadil | 54 | 180 | £2.2K | +215.7% ▲ |
| Potassium chloride | 54 | 2,700 | £267 | +188.9% ▲ |
| 54 | 25.9K | £229 | -40.8% ▼ | |
| Desloratadine | 53 | 2,976 | £434 | +83.8% ▲ |
| Amisulpride | 53 | 3,398 | £961 | -24.6% ▼ |
| Insulin Lispro | 53 | 554 | £3.9K | -30.7% ▼ |
| Goserelin acetate | 53 | 53 | £7.4K | +20.3% ▲ |
| Metronidazole | 53 | 2,395 | £1.2K | +41.0% ▲ |
| Terbinafine hydrochloride | 52 | 2,580 | £478 | +40.1% ▲ |
| Ipratropium bromide | 51 | 2,504 | £716 | +77.4% ▲ |
| Specialist food replacer flour type mixes (0913271) | 51 | 83.5K | £1.3K | +123.4% ▲ |
| Febuxostat | 51 | 2,940 | £240 | +36.5% ▲ |
| Lacidipine | 50 | 1,960 | £173 | -58.2% ▼ |
| Ciclesonide | 50 | 67 | £1.7K | +239.6% ▲ |
| Magnesium glycerophosphate | 50 | 7,566 | £5.1K | +263.9% ▲ |
| Sodium fluoride | 50 | 4,425 | £489 | +50.7% ▲ |
| Permethrin | 50 | 4,228 | £1.3K | +32.7% ▲ |
| Colestyramine | 49 | 4,738 | £2.5K | +70.1% ▲ |
| Rifaximin | 49 | 3,054 | £13.5K | +82.5% ▲ |
| Ondansetron hydrochloride | 48 | 2,769 | £1.2K | -1.1% vs avg |
| Cenobamate | 48 | 1,680 | £8.6K | +98.1% ▲ |
| 48 | 727 | £1.3K | +29.6% ▲ | |
| Valsartan | 47 | 3,052 | £804 | -20.2% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.